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Abstract
OBJECTIVES—Our goal was to report the prevalence of elevated blood pressure and lipid levels
among eighth-grade adolescents from 3 US locations and differences by gender, ethnicity, and
overweight percentile group.
METHODS—Fasting blood samples and blood pressure levels were obtained from 1717 eighth-
grade students from 12 predominantly minority schools in 3 states (Texas, California, and North
Carolina) during spring 2003. Age, gender, ethnicity, weight, and height were ascertained and BMI
calculated. The presence of abnormal total cholesterol, high-density lipoprotein cholesterol, low-
density lipoprotein cholesterol and triglycerides, prehypertension, hypertension, at risk for
overweight, and overweight were calculated and compared with the findings of previous youth
studies. We examined whether prevalence differed by gender, ethnicity, or BMI group.
RESULTS—A total of 23.9% of participants had high blood pressure, 16.7% had borderline total
cholesterol, 4.0% had high total cholesterol, 10.5% had borderline low-density lipoprotein
cholesterol, 3.9% had high low-density lipoprotein cholesterol, 13.3% had low high-density
lipoprotein cholesterol, and 17.2% had high triglycerides. A total of 19.8% of participants were at
risk of overweight (BMI ≥85th percentile, <95th percentile) and 29% were overweight (BMI ≥95th
percentile). The prevalence of risk factors was associated (P < .05) with the overweight group and
differed by age and gender.
CONCLUSIONS—Prevalence of elevated blood pressure was higher in this sample than in previous
national surveys in which subjects were less overweight. Associations between overweight and both
elevated lipid and blood pressure levels suggest that adolescents overweight or at risk for overweight
should be screened for elevated blood pressure and lipid levels.
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ELEVATED LIPID1 and blood pressure2 levels have been associated with an increased risk of
cardiovascular disease and track from childhood to adulthood3-6 suggesting that the presence
of elevated lipid or cholesterol levels during adolescence increases the risk of adult disease.
Lipid levels and blood pressure levels have also been reported to vary by ethnicity,7-10 gender,
7,9 and Tanner stage11,12 among children and adolescents.
In the Bogalusa Heart Study (1984-1994), 11.4% of 11- to 17-year-olds were overweight
(Quetelet index), 9% had high total cholesterol (TC) levels (>200 mg/dL), 8% had high (>130
mg/dL) low-density lipoprotein cholesterol (LDL-C), and 11% had low (<35 mg/dL) high-
density lipoprotein cholesterol (HDL-C).13 Recent data from the National Health and Nutrition
Examination Survey (NHANES) 1999-2000 showed that the prevalence of high triglycerides
and low HDL-C remained virtually unchanged since NHANES III (1998-1994) among 12- to
19-year-olds at 23.2% and 23.4%.14 However, the prevalence of elevated blood pressure among
12- to 19-year-olds had increased to 8.0% among all participants, 7.5% among white children,
11.3% among Mexican American children, and 12.7% among black children. The prevalence
of overweight has been increasing among US adolescents.15 Overweight has been associated
with dyslipidemia13,16 and increased blood pressure13,17,18 among both children and
adolescents. As the prevalence of overweight has increased since NHANES 1999-2000 (from
15.0% in 1999-2000 to 16.5% in 2001-2002),19 there is a need to report the prevalence of
cardiovascular risks among adolescents and particularly minority adolescents during the
current obesity epidemic.
This study reports the prevalence of elevated lipid and blood pressure levels among eighth-
grade adolescents sampled from 3 ethnically diverse locations in the United States overall and
according to ethnic group, overweight status, and gender during the spring of 2003.
METHODS
Data were collected as part of a pilot feasibility study conducted by the Studies to Treat or
Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Prevention Study Group, a National Institute
of Diabetes Digestive and Kidney Disease multisite study designed to reduce the prevalence
of type 2 diabetes mellitus among middle school children. At the time of data collection, the
study was comprised of 3 field centers in Texas (Baylor College of Medicine, Houston, TX),
California (University of California Irvine, Irvine, California), and North Carolina (University
of North Carolina, Chapel Hill, NC), and a coordinating center (George Washington University
Biostatistics Center, Rockville, MD).
Inclusionary Criteria and Recruitment
Participants were recruited from 12 schools, 4 schools at each of the 3 field centers. To
participate in the study, at least 50% of the students enrolled at the school were required to be
from an ethnic minority known to be at increased risk for type 2 diabetes mellitus (black, Native
American, or Hispanic). Schools were also required to have at least 50% of their students
eligible for free or reduced-price school lunch. Because participants were required to undertake
an oral glucose tolerance test to determine the prevalence of type 2 diabetes (results reported
elsewhere), consented students were required to be free from a current diagnosis of either type
1 or type 2 diabetes. With this exception, all eighth-grade students in the study schools who
provided written parental informed consent and informed assent were eligible to participate in
the study. Social marketing campaigns that included diabetes information sheets, student,
teacher, and parent information sessions were implemented in each school to recruit students.
Consent and assent were sought for a health screening that included medical history, pubertal
development, blood pressure, and the provision of a fasting blood sample. Participants received
$50 and a free breakfast for participating in the study. The Baylor College of Medicine,
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University of California, Irvine, and University of North Carolina institutional review boards
approved this study.
Procedures
Participant ethnicity was obtained by student self-report. Height was measured to the nearest
0.1 cm on a stadiometer (PE-AIM-101; Perspective Enterprises, Kalamazoo, MI) with the
participants shoeless and the head in the Frankfort plane. Body mass was measured to the
nearest 0.1 kg using a precalibrated electronic scale (SECA Alpha 882; Vogel and Halke,
Hamburg, Germany). Research assistants who were within 90% agreement with a criterion
observer during a prestudy training and certification procedure recorded all measurements.
Body mass index (BMI) was then calculated (kg/m2). Participants’ BMI percentile was then
calculated using Centers for Disease Control and Prevention (CDC) age- and gender-specific
percentiles20 and participants were grouped as normal weight (BMI <85th percentile), at risk
of becoming overweight (85th ≥ BMI <95th percentile), and overweight (BMI ≥95th
percentile).
Pubertal development was measured by using the Pubertal Development Scale (PDS).21 The
PDS has a 5-item subscale for each gender. Items were coded on a 4-level ordinal response
and the results summed across the 5 items to produce a 5-level Tanner score. The PDS has
been shown to have good associations with physician ratings of Tanner stage.21
Blood pressure was recorded 3 times by trained research assistants using an automated blood
pressure monitor (Omron HEM-907; Vernon Hills, IL). The initial value was recorded after
the participant had been seated quietly for 5 minutes with each subsequent value recorded 1
minute after the preceding recording. An appropriate-sized cuff was used for all participants.
An adult automated blood pressure monitor (DinaMap Procare 100; GE, Tampa, FL) was used
for participants whose upper arm circumference exceeded 42 cm. The mean of the second and
third recordings were used in all subsequent analyses. Blood pressure percentiles were
determined using the National Heart Lung and Blood Institute guidelines and adjusted for age,
gender, and height percentile22 with prehypertension being classified as either systolic or
diastolic blood pressure between the 90th and 95th percentiles, and hypertension classified as
systolic or diastolic blood pressure above the 95th percentile. A third variable, any high blood
pressure (HBP), was also created and classified as either systolic or diastolic blood pressure
above the 90th percentile. Because participants could have a systolic blood pressure level that
was prehypertensive and a diastolic blood pressure level that was hypertensive (or vice versa),
participants with both a prehypertensive and hypertensive blood pressure level were counted
only once.
Participants were asked at the beginning of the blood screening when they last ate and whether
they were taking lipid-lowering or hypertensive medications. Participants who reported eating
after midnight were considered nonfasting and asked to return another day. No participant
reported taking lipid-lowering or antihypertension medications. Experienced pediatric
phlebotomists obtained fasting blood samples and placed at least 2.0 mL of plasma in an EDTA
tube; the tube was frozen and sent to the central laboratory at the University of Washington.
Measurements of TC in plasma, cholesterol in the lipoprotein fractions, and triglycerides were
performed enzymatically using a Hitachi 917 autoanalyzer and methods standardized to the
CDC reference methods using standard laboratory procedures.23-26 Quality control procedures
(BCL-Low, BCL-High [Biocell Laboratories]) were performed at the beginning and end of
each run. The interassay coefficients of variation are consistently <1.5% for TC and
triglycerides and <2% for HDL-C.
Abnormal lipid levels were defined using the following National Cholesterol Education
Program (NCEP) guidelines27: borderline TC, 170-199 mg/dL (4.58-5.15 mmol/L28); high
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TC, ≥200 mg/dL (5.17 mmol/L28); borderline LDL-C, 110-129 mg/dL (2.84-3.34 mmol/
L28); high LDL-C, ≥130 mg/dL (3.3 mmol/L28); and low HDL-C, <35 mg/dL (0.9 mmol/
L28). Because the NCEP criteria do not include a definition for elevated, triglycerides a
definition of >110 mg/dL (1.24 mmol/L28), which is based on the criteria of Cook and
associates29 and was developed from pediatric norms, was used in this study. Adoption of this
criteria also allowed comparison with data from the 1999-2000 NHANES study.14
Statistical Methods
Because students with a previous diagnosis of diabetes were excluded from the study, we also
excluded the 8 participants who possessed fasting glucose levels that were suggestive of type
2 diabetes (>126 mg/dL). Descriptive statistics, including means, standard deviations, and
percents, were calculated for all variables. Separate generalized estimating equation (GEE)
models that took into account clustering of observations within schools were used to analyze
differences in the percent of students with elevated lipid and blood pressure values by
categorical groupings (gender, BMI group, and Tanner stage). Equal correlation between all
interschool observations (exchangeable) was chosen as the covariance structure. A multivariate
approach was used to examine the possible interactions among gender, ethnic group, and BMI
percentile in the prevalence of each of the risk factors. Models that included each of the main
effects and the 2-way interactions were computed. However, because BMI percentile and
ethnicity were highly correlated, this interaction was not included in the models, leaving only
the gender*ethnicity and gender*BMI percentile interaction terms. All nonsignificant
interaction terms were subsequently removed and the models rerun. Significant interactions
were graphed. All P values represent exploratory findings and are presented without adjustment
for multiple comparisons with α set at .05. SAS 8.2 statistical software (SAS Institute Inc, Cary,
NC) was used for all statistical analyses.
RESULTS
A total of 1740 eighth-grade students provided informed consent. An average of 144 (range:
85-199) students per school were recruited. The mean recruitment rate (participants/total
number of available eighth-grade students) was 50% per school with a range of 33% to 67%
per school. Comparing consented participants with previously established heights and weights
of all students within the school indicated that participants in each school were representative
with regard to the percent of students with BMI ≥85th percentile, percent by gender, and percent
minority compared with the entire eighth-grade student population of each school. Table 1
presents descriptive statistics for the 1717 eighth-grade students for whom complete lipid and
blood pressure data were obtained. Overall, the sample was 56% female, 50% Hispanic, 22%
black, 14.3% white, and 2% Native American. Ethnic distributions varied by site, with the
Texas participants 69% Hispanic, 27% black, and 1% white, the California students 77%
Hispanic, 13% white, and 2% black, and the North Carolina participants 48% black, 31% white,
4% Hispanic, and 8% Native American. All other participants described themselves as being
of mixed heritage or other ethnic groups.
The students were 13.6 ± 0.6 years of age. There was little difference in self-reported Tanner
stage with 81% of the boys reporting Tanner stage 3 or 4 and 92% of the girls reporting Tanner
stage 4 or 5. The rates of elevated blood pressure ranges from 12.8% of participants who were
prehypertensive to 23.9% who had any HBP. The prevalence of elevated lipid levels ranged
from 3.9% who had borderline LDL-C to 17.2% who had high triglyceride levels. Across the
3 sites, 19.8% of the participants (18.2% Texas, 9.8% California, and 21.6% North Carolina)
were at risk for overweight (BMI ≥85th percentile <95th percentile), whereas 29% (31.8%
Texas, 30.1% California, and 24.4% North Carolina) were overweight (BMI ≥95th percentile)
based on the CDC age- and gender-specific percentiles.20
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The percent of participants with elevated blood pressure and lipid values is shown in Table 2.
Boys were more likely to have elevated HBP than girls. Significantly more girls than boys had
borderline TC, whereas significantly more boys than girls had low HDL-C cholesterol. There
was a statistically significant difference in the percent of participants with low HDL-C among
the ethnic groups with a lower prevalence among the black children than all other ethnic groups.
There was a statistically significant difference in the percent of participants with high
triglycerides among the ethnic groups with an increased prevalence among the Hispanics in
comparison to all other ethnic groups.
Table 3 displays the percent of participants with elevated blood pressure and dyslipidemia for
normal weight, at risk of overweight, and overweight participants. Among all students, and
separately for both boys and girls, the percent who were prehypertensive, hypertensive,
hypertensive, or had any HBP, low HDL-C, or high triglycerides increased with increasing
BMI group. For all students and for boys only, the percent with borderline TC and borderline
LDC-C increased with increasing BMI group. Among boys only, high TC increased with
increasing BMI group.
There were no differences in the prevalence of lipid or blood pressure risk factors by pubertal
development (as defined by Tanner stage) or level of parental education (data not shown).
Among lipids, only the percent of students with high triglycerides increased with increasing
blood pressure. The prevalence of high triglycerides was 14.7% among participants with
normal blood pressure, 22.7% among prehypertensive participants, and 27.1% among
hypertensive participants (P = .001).
Table 4 shows the percent of participants with elevated blood pressure and lipid levels for both
genders in each of the 4 largest ethnic groups. GEE regression models were used to predict
elevated blood pressure and lipid levels while simultaneously adjusting for gender, BMI group,
ethnic group, and relevant interaction terms. There were significant gender*ethnicity
interactions in the percent with prehypertension (P = .03) and any HBP (P = .02), indicating a
higher prevalence of prehypertension and any HBP among white boys than girls (Fig 1). The
prevalence of prehypertension and any HBP increased with BMI group (P = .012 and .009,
respectively). For any HBP only, boys had overall higher rates of BMI (P = .009). For
hypertension, the gender*ethnicity interaction approached significance (P = .052), suggesting
more hypertension among white boys than girls. In the same model, more boys than girls were
hypertensive (P = .009), and the prevalence of hypertension increased with BMI group (P = .
018).
There were no significant interactions in any models predicting elevated lipid levels. Gender
(P = .045) and BMI (P = .032) predicted the percent of participants who had borderline high
TC, whereas only BMI was a significant (P = .011) independent predictor of borderline LDL-
C. Gender (P = .007), BMI (P = .018), and ethnicity (P = .024) all independently predicted the
percent of student with low HDL-C. BMI (P = .014) and ethnicity (P = .022) independently
predicted the percent of students with high triglycerides.
DISCUSSION
In the NHANES 1999-2000 study, 8.0% of participants had HBP (blood pressure >90th
percentile for age, gender, and height), but much higher levels were found in this study for all
participants regardless of ethnic subgroups.14 There was also a higher prevalence of elevated
blood pressure in this study than in NHANES 1999-2000 across all the BMI groups. (A
summary of the prevalence rates in NHANES 1999-2000 and this study is shown in Table 5.)
Our higher prevalence was obtained using only eighth-grade participants, whereas the
NHANES sample included 12- to 19-year-olds. The high prevalence of elevated blood pressure
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among this sample is concerning because HBP has been reported to track from childhood to
adulthood,5,6 and adult HBP has been associated with increased risk of stroke and
cardiovascular disease.2
Contrary to research in adults that has shown higher hypertension rates among blacks,30,31 we
found no ethnic differences in the prevalence of hypertension, prehypertension, or any HBP
in this cohort. This is consistent with a recent study of hypertension among Houston, Texas,
schools, which found no evidence of ethnic differences in the prevalence of hypertension
among 5102 10- to 19-year-old children after controlling for BMI.18 The higher prevalence of
hypertension among our sample than in NHANES 1999-2000 is therefore, likely to be a
function of greater number of participants in this study (29% vs 15.5%) who were overweight
(BMI >95th percentile).15
The prevalence of high triglycerides was lower in this sample (17.2%) than in NHANES
1999-2000 (23.2%) for all participants and all gender, ethnic, and BMI subgroups using the
same cut point (≥110 mg/dL).14 The prevalence of high TC (4.0%) and high LDL-C (3.9%)
was lower in our sample than in the Bogalusa sample from 1984-1994, in which prevalence
rates of 9% and 8% were reported using the same cut points.13 The lower prevalences of high
triglycerides and TC in this study could be a function of the limited age of participants in this
study (all eighth grade) compared with the 11- to 17- and 12- to 19-year-old ranges used in the
Bogalusa and NHANES 1999-2000 studies. Given the advanced Tanner stage of the study
participants and the known reductions in LDL-C that occur with puberty,32 the lower
prevalence found in this study could be a function of participants pubertal stage.
More boys than girls in this cohort were categorized as hypertensive. There was also a gender-
by-ethnicity interaction in the prevalence of hypertension and any HBP with a higher
prevalence of both prehypertension and any HBP among white boys than girls. These findings
are consistent with previous reports18 and suggest that there is a need to focus on reducing
HBP among early male adolescents. Similar to NHANES 1999-2000, there was an increased
prevalence of low HDL-C among the boys in this sample.14 More girls than boys had borderline
TC, which is consistent with previous research that has reported higher TC levels among girls.
33 The implication of these findings is that gender-specific strategies to reduce the TC of girls
and increase the HDL-C levels of boys may aid the prevention of cardiovascular diseases.
The lower prevalence of HDL-C levels among black children in this study is similar to the
findings of NHANES 1999-2000, which also reported a lower prevalence of low HDL-C
among black children.14 We found an increased prevalence of high triglycerides among the
Hispanic participants, which is also similar to the findings of NHANES 1999-2000.14 These
findings suggest that there is a need to develop specific strategies to decrease triglyceride levels
of Hispanics.
The association between higher BMI and increased lipid and blood pressure levels suggest that
lipid screenings should be recommended for all children and adolescents with BMI >85th
percentile for age and gender. Although regular blood pressure screenings are common, current
NCEP guidelines call for the screening of all children and adolescents with a family history of
elevated lipid levels, atherosclerosis, or other cardiovascular illnesses as well as those children
with other risk factors.27 Because increases in blood pressure were associated with elevated
triglyceride levels, the results of this study suggest that lipid screenings should be
recommended for all participants who are either at risk for overweight or with elevated blood
pressure levels.
Although lipid8,11 and blood pressure levels11,12 have previously been shown to vary by
developmental stage, we detected no such relationships in this study. Because 92% of the girls
were categorized as either Tanner stage 4 or 5 and most of the boys categorized as Tanner stage
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3 or 4, this is likely a function of the lack of variability within the sample. Additional research
that includes a wider distribution of pubertal groups is required to examine the association
between developmental stage and the prevalence of cardiovascular risk factors.
The prevalence of elevated blood pressure and lipid levels did not differ by parental educational
attainment in this sample. This is contrast to previous studies that have reported differences in
the lipid and blood pressure levels of children from high or low socioeconomic schools.33
Because schools were required to have at least 50% of their students eligible for free or reduced-
price lunch to participate in the study, this is likely a function of study design. Additional
research that includes greater distribution of parental education is required to fully examine
whether the prevalence of cardiovascular risk factors differs by socioeconomic status in a
diverse group of adolescents.
Strengths and Limitations
The major strength of this study is the large, ethnically diverse sample that was obtained from
3 distinct geographic regions within America during the current obesity epidemic. This has
enabled us to report the prevalence of risk factors and compare our findings with those of
previous studies. The sample is, however, limited by a small age range and the lack of variability
in the pubertal development of the participants, which prevented us from fully exploring the
relationship between pubertal development and prevalence of risk factors. Because diabetics
(either type 1 or type 2) were excluded from the study and the analyses, it is possible that the
prevalence of elevated lipid levels could be underestimated. Furthermore, although this sample
was purposely selected to provide information about risk among adolescents from low-income
homes, this restricted our ability to assess changes in the prevalence of risk and was limited
by a lack of diversity in socioeconomic status. It is also important to acknowledge that we did
not assess the participants’ diet,34,35 habitual physical activity level,36 or tobacco use37 in this
study, which could be important because all 3 factors have been associated with increased
prevalence of cardiovascular risk factors in adolescents.
CONCLUSIONS
The data presented here show that the prevalence of hypertension among this sample of
minority adolescents was greater than previous national surveys, with this increase likely a
function of the increased levels of overweight among this sample. Curbing the pediatric obesity
epidemic is necessary to reduce the disease risk of US adolescents, and lipid and blood
pressures screenings should be considered for youths at risk for overweight.
ACKNOWLEDGMENTS
This work was completed with funding from National Institute of Diabetes and Digestive and Kidney Diseases/
National Institutes of Health grants U01-DK61230 (George Washington University), U01-DK61249 (University of
California, Irvine), U01-DK61231 (Baylor College of Medicine), and U01-DK61223 (University of North Carolina
at Chapel Hill). The following individuals and institutions contributed to the reported results as members of the STOPP-
T2D Prevention Study Group (*members of the writing group): Field Center (Baylor College of Medicine): T.
Baranowski, PhD, J. Baranowski, MS, RD, LD, A. Canada, K. Cullen, DrPH, RD, LD, *R. Jago, PhD, M. Missaghian,
MS, MPH, D. Thompson, PhD, V. Thompson, DrPH, and B. Walker, RN; Field Center (University of California,
Irvine): D. M. Cooper, MD, *S. Bassin, EdD, K. Blackler, F. Culler, MD, D. Ford, and P. Galassetti, MD, PhD; Field
Center (University of North Carolina at Chapel Hill): *J. Harrell, PhD, RN, *R. G. McMurray, PhD, J. Buse, MD, T.
Hackney, PhD, D. Rubin, PhD, M. A. Morris, MD, and K. Kirby; Coordinating Center (George Washington
University): K. Hirst, PhD, *S. Edelstein, ScM, *L. El Ghormli, MSc, S. Grau, MA, and L. Pyle, MS; Program Office
(National Institute of Diabetes and Digestive and Kidney Diseases): B. Linder, MD, PhD; Central Blood Laboratory
(Northwest Research Lipid Laboratories): S. Marcovina, PhD, ScD. STOPP-T2D Study Chair: F. R. Kaufman, MD
(Childrens Hospital Los Angeles); other study group members: M. Goran, PhD (University of Southern California),
and K. Resnicow, PhD (University of Michigan).
Jago et al. Page 7














LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol;
NHANES, National Health and Nutrition Examination Survey; CDC, Centers for Disease
Control and Prevention; PDS, Pubertal Development Scale; HBP, high blood pressure; TC,
total cholesterol; NCEP, National Cholesterol Education Program; GEE, generalized
estimating equation.
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Prevalence of HBP (either systolic or diastolic blood pressure ≥90th percentile) by ethnicity
and gender indicating significant gender differences for white children.
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TABLE 5
Prevalence of Any HBP in This Study and NHANES 1999-2000 for All Participants and for Ethnic and BMI
Subgroups
This Study, %a NHANES 1999-2000, %b






 Normal weight (BMI <85th percentile) 14.2 4.4
 At risk for overweight (BMI ≥85th to <95th
percentile)
27.1 6.0
 Overweight (BMI ≥95th percentile) 39.1 25.6




Participants 12 to 19 years of age.
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